Ceramic Implants with Biodegradable Polymer Coatings for Controlled Drug Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing implantable compositions for bioactive agent delivery often experience premature release and lack selectivity in drug release profiles, making them unsuitable for varied therapeutic needs.
Innovation Solution
The development of implantable compositions featuring ceramic substrates with bioactive agents loaded on their surfaces and coated with biodegradable polymers, allowing for multiple zones with different degradation periods to achieve customizable release profiles, reducing the risk of premature release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If a long-term biodegradable coating is used to provide sustained release, then the duration of drug delivery is extended, but premature release of the bioactive agent occurs through the coating layer
Solution Approach 1:
The coating is segmented into multiple layers with different degradation rates. The fast-degrading layer provides initial protection while the slow-degrading layer ensures sustained release, preventing premature release through the entire coating structure while maintaining extended duration delivery
Solution Approach 2:
Different regions of the coating have different properties - the outer layer has faster degradation rate for initial release control, while inner layers have slower degradation rates for sustained release, creating spatial variation in degradation behavior that prevents premature release while extending duration
2Device complexity
If passive drug releasing implants are used to provide constant rate release, then the device complexity is reduced, but the ability to provide selective and adaptable release profiles is limited
Solution Approach 1:
The degradation parameters of the coating layers are varied - different polymer compositions, molecular weights, and thicknesses are used to create layers with distinct degradation rates. This allows the same passive implant structure to provide adaptable release profiles by changing material parameters rather than device architecture
Solution Approach 2:
The coating is formed as a composite structure combining multiple biodegradable polymer materials with different degradation characteristics. This composite approach enables selective release profiles while maintaining the simplicity of a passive implant design, as the material composition itself provides the release control mechanism
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables selective and adaptable bioactive agent release, providing improved control over drug delivery profiles, enhancing therapeutic efficacy and minimizing premature release risks.
Implementation Method 1
a biodegradable polymer having an in vivo degradation period, forming a continuous or discontinuous coating on an area of a said ceramic substrate
Implementation Method 2
a bioactive substance loaded on a surface of a said ceramic substrate forming a loaded surface zone operable to release said bioactive substance according to a release profile under physiological conditions
Data Source
AI summary
Implantable compositions providing release of bioactive agents according to a predetermined release profile and methods for their use. Such compositions include at least one ceramic substrate; a bioactive substance loaded on a surface of the ceramic substrate forming a loaded surface zone operable to release said bioactive substance according to a release profile under physiological conditions; and a biodegradable polymer having an in vivo degradation period, forming a continuous or discontinuous coating on an area of the ceramic substrate.